NLARx Newsletter Header
NLARx News
February 27, 2008
In This Issue
NLARx News
Action Alert: Join Petiition
Tools to Use
In the States
Outrage of the Week
Fraud & Abuse
Conflicts of Interest
Advertising & Marketing
Confidentiality
Pharma Watch
Prices & Health Costs
PBM Watch
Medicare
Medicaid
Goings on in Congress
Safety & Clinical Trials
Generics & Patents
Importation
Editorials
Resources & Reports
Quick Links
Join Our Mailing List
NLARx in the News
SAVE THE DATE!! Next NLARx Meeting May 9, 2008 in Charleston, West Virginia.  Stay tuned for details.
Action Alert: DTC Advertising Petition
Should TV drug ads include a toll-free number for reporting drug side effects to the FDA? Consumers Union thinks TV ads shouldn't be exempted from the law requiring other DTC ads to include this info.  Find out more and join CU's petition: More
Tools You Can Use: Their Arguments
Check out the NLARx collection of industry documents opposing the Washington State datamining bills. More
In the States
MULTI-STATE OVERVIEW: Amid Court Challenges, Legislators Work to Protect Prescription Privacy More
WASHINGTON DATAMINING BILL PASSES SENATE, HEADS TO HOUSE:  Bill Makes It Illegal for Drug Makers to Buy Prescription Data for Marketing More
Data Mining Ban in for Tough Battle More
Industry Documents Attacking Datamining Bills More
WEST VIRGINIA: Delegate Don Perdue's Bill to Limit Datamining of Prescriber Records More

CALIFORNIA: AB 2842 Would Crack Down on Deceptive Marketing of Medicare Products More
NEW YORK: Price Comparison Website Unveiled More
WISCONSIN: Bill Would Revert to HIPAA Rules More
COLORADO: Discount Law Helps Coloradans More
MONTANA: AG Sues Over Antipsychotics More

VERMONT: Senate Committee Holds Hearing on Pharmaceutical Patents Act More

VERMONT: State to Receive More Than $1M in Multistate Caremark Drug-Switching Settlement More
MARYLAND: Seniors May Get Subsidies for Drugs More
OHIO: Board Investigates Prescription Errors More
MICHIGAN: Supreme Court Struggles with Michigan Law Shielding Pharma from Lawsuits More
Outrage of the Week
FDA Says it Approved the Wrong Drug Plant More
Fraud & Abuse
CVS Caremark Settles Deceptive-Practices Complaint for $38.5 Million More
Jury Awards Alabama $215M in Lawsuit That Claimed AstraZeneca Overcharged Medicaid More
New Jersey AG Subpoenas Amgen Documents on Enbrel Marketing More
Barr Pharmaceuticals Settles With States More

Conflicts of Interest
Study: Only 38% of U.S. Medical Schools Have Policies to Prevent Conflicts of Interest More
Academic Medical Centers and Financial Conflicts More
Med Schools Lack Conflict-of-Interest Rules More
Pennsylvania Medical Center Regulates Providers' Contacts With Rx, Device Makers More
Advertising & Marketing
FDA Proposes Rule Loosening Restrictions on Off-Label Prescription Drug Promotion More
Pharma's New Marketing Partner: Medical Journals More
Pfizer to End Lipitor Ads by Jarvik More
Ranking 2007's Most Memorable TV Drug Ads More
Drug Ads to Get More FDA Scrutiny More
Congress Likely To Debate Source of Funds for FDA Oversight of DTC Drug Ads More
Drugmakers Asked to Reveal Educational Grants to Doctors More

Tracking of Marketing Spending Data Widens More
Legalizing Direct-to-Consumer Communication by Pharmaceutical Companies More

Confidentiality
Google Partners With Cleveland Clinic To Allow Storage of Patient Health Records Online More
Google PHR Pilot Has Caveat: No HIPAA Protection More
Pharma Watch
Drug Trade Group Spent $22M Lobbying More
Generic Trade Group Spent $818,000 in 2007 to Lobby Feds More
Global Access to Medicines Bulletin: High Drug Prices, Access to Medicines and the Cost of R&D More
Prices & Health Care Costs
Drug Prices of Top 50 Drugs Rose 7.8% in 2007 More
Drug Companies Continue To Raise Prices Despite Presidential Candidates' Criticism More
GSK To Reduce Cost of 14 Antiretrovirals Sold in Developing Nations More

Report: State Drug Price Comparison Web Sites Often Lack Information, Provide Outdated Data More
Taxpayer Health Care Spending to Hit $4.3 Trillion by 2017 More
More Consumers Buying Medicines by Mail More
PBM Watch
Amid Success, Medco Faces Changes: An Interview with CEO David Snow More
Express Scripts sees 'tremendous opportunity' in specialty pharmaceuticals More
Medicare
Bush Medicare Proposals Would Increase Drug Benefit Premiums for Higher-Income Beneficiaries More
Bush Proposes Linking the Medicare Drug Premium to Beneficiaries' Income More
CMS Places Marketing, Enrollment Freeze on Health Net Prescription Drug Plans More
Medicaid
Governors Push For Second Stimulus Package More
CMS Proposes Rule To Give States 'Unprecedented Flexibility' in Designing Medicaid Programs More
More Goings on in Congress
Senate Special Committee on Aging Holds Hearing on Kickbacks by Medical Device Makers More
Congressional Democrats To Draft Bill To Overturn Supreme Court Decision on Medical Devices More
GAO To Investigate Whether FDA Has Adequate Resources More
Safety & Clinical Trials
Supreme Court Adds Legal Complications to Debate on FDA's Competence More
FDA Leader Agrees Agency Needs Money to Function Properly More
FDA Draft Guidance For Articles on Unapproved Product Uses More
Avastin Nod Shows Evolving FDA Thinking More

Court May Protect Drugmakers from Lawsuits More

China Plant Had Role in Drug Tied to Four Deaths More
USA Today Examines Confidentiality Agreements, Patient Counseling in Series on Medication Errors More
Administration Fails to Comply With Subpoena for Documents Related to FDA Approval of Ketek More
Generics & Patent Policy
Follow-on Biologics Could Save $378 Billion Over Next 20 Years, Economist's Report Says More
Biotechnology Industry Seeks Passage of Bill to Allow FDA Approval of Generic Biotech Medications More
Sen. Schumer Stresses Key Principles for Generic Biotech Drugs Legislation More
Coalition (CCPM) Endorses Biogenerics Legislation More
FTC Sues Cephalon for Blocking Sale of Lower-Cost Generic Versions of Branded Drug More
Lawsuit Claims Cephalon Delayed Sale of Generics More
Generics Hit Highest-Ever Prescription Rate More
Generic Growth Slowed To 3.8 Percent In 2007 More
US Patent Reform Seen Helping Indian Firms More

Importation
Election 2008: Next President Likely to Allow Prescription Drug Reimportation More
Editorials
Boston Globe: A Line between Docs and Drugs More
Alternative View: There's Nothing Wrong With Letting Drug Reps Schmooze With Doctors More
NY Times: Lipitor's Pitchman Gets the Boot More

NY Times: Constraining the Medicare Debate More
FDA Commissioner Jon Leibowitz Op-Ed: How Collusion Keeps Generic Drugs Off the Shelves More
Resources & Reports
Journal of Health Affairs: The U.S. Economy and Changes in Health Insurance Coverage, 2000-06 More
Summary and Presentations from the Academic Detailing Informational Summit, Concord, NH More